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Zachary A Klase1, Gavin C Sampey2 and Fatah Kashanchi2*Abstract
The encoding of microRNAs in retroviral genomes has remained a controversial hypothesis despite significant
supporting evidence in recent years. A recent publication demonstrating the production of functional miRNAs from
the retrovirus bovine leukemia virus adds further credence to the fact that retroviruses do indeed encode their own
miRNAs. Here we comment on the importance of this paper to the field, as well as examine the other known
examples of miRNAs encoded by RNA viruses.
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The importance of microRNAs (miRNAs) and other small
non-coding RNAs (sncRNAs) in human disease is becom-
ing increasingly evident. In viral infections of humans, the
outcome of infection can be influenced by miRNAs
encoded by both the cell and the virus [1]. For DNA
viruses, several hundred viral miRNAs have been
described; however, the description of miRNAs derived
from RNA viruses is relatively rare. A paper recently
published in the Proceedings of the National Academy of
Sciences by Kincaid et al. describes several miRNAs
encoded by the retrovirus bovine leukemia virus (BLV).
The authors demonstrate that these miRNAs are encoded
on RNA polymerase III (Pol III) transcripts and identify
one that mimics a cellular oncogenic miRNA [2]. While
the Pol III transcription of miRNAs has been identified pre-
viously in DNA viruses and higher organisms [3], this is the
first description of Pol III based miRNA transcription from
a RNA virus. In this work, the authors failed to identified
Pol III transcribed miRNAs from the five retroviruses of
the subfamily Spumaretrovirinae they examined but did de-
tect numerous miRNAs from the one Orthoretrovirinae
member they tested, specifically BLV. Despite the lack of
identifying Pol III transcribed miRNAs from the limited set
of other retroviruses examined, it is likely that additional
RNA viruses will be found to encode Pol III transcribed
miRNAs due to the evolutionary conservation of this* Correspondence: fkashanc@gmu.edu
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reproduction in any medium, provided the ormechanism. Furthermore, the ability of an RNA virus to
produce miRNAs from a Pol III transcript, as demonstrated
in this paper, provides a mechanism by which RNA viruses
can produce miRNAs while avoiding any detrimental
effects on its own transcribed genome, such as cleavage by
the Drosha/DGCR8 Microprocessor complex.Discussion
The work done by Kincaid et al. is a welcome discovery
that should alter a common misconception that RNA
viruses cannot encode miRNAs. In light of these find-
ings, we wish to discuss a general set of rules regarding
the presence of viral miRNA in infected cells. They
include:
1. Viral miRNAs or other functional sncRNAs must be
detectable at least by deep sequencing methods and
mediate a biological effect. Importantly, these
findings must be experimentally verified by multiple
methods and multiple labs.
2. The function of the viral miRNA must be described
and conserved.
3. The miRNA sequence must be conserved across
clades.
Taking these three points into consideration, we propose
that BLV derived miRNAs are actually the third instance
of an RNA virus that expresses miRNAs. The other two
examples are HIV-1 and West Nile Virus (WNV), of
which HIV-1 has been studied to the greatest extentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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examined when testing the existence of all future viral
miRNAs.
To the first point for HIV-1, in 2004 Bennasser et al.
reported on potential HIV-1 encoded miRNA candidates
and their likely cellular targets using computer algorithms
[4]. Then in 2007, our lab first verified that HIV-1 con-
tained miRNAs by using a number of in vitro assays [5]
and later by cloning of the mature miRNAs derived from
both the 50 and 30 end of the TAR structure [6]. Since that
time these findings have been confirmed by several inde-
pendent labs. For instance, Berkhout and colleagues uti-
lized state of the art SOLiD deep sequencing technology
to analyze over 16 million sequences including 5 million
small RNA sequences of which 2.6 × 104 were HIV-1
specific sncRNAs [7]. They identified sncRNAs from the
TAR element as the most prominent and many anti-sense
sequences from the negative strand that could function as
siRNAs. Previous pyrosequencing of HIV-1 sncRNAs by
the Jeang lab also showed TAR derived miRNAs to be the
most prevalent with a copy number of 3 × 103 copies per
cell, which is comparable to the highest expressing host
miRNAs [8]. While the specific copy number of the indi-
vidual BLV derived miRNAs was not given, counts for
each BLV miRNA sequence of up to 4.9 × 104 exceeded
the maximum 3.6 × 104 counts of the highest expressing
host cell miRNA [2]. These relatively high miRNA counts
of both the BLV and HIV-1 encoded miRNAs indicate the
biological relevance of each. More recently, Althaus et al.
developed and employed an enrichment strategy that iso-
lated low abundance HIV-1 derived sncRNAs that boosted
their proportion in the cloned pool by over 100-fold [9].Figure 1 Expression and biological function of miRNAs encoded by th
WNV, respectively, have been shown to encode functional miRNAs within t
varied responses including increased cell survival and viral replication, as w
Additionally, the biosynthesis of the miRNAs from each virus has been sho
diverges from the canonical host miRNA maturation process.The sncRNA sequences derived from this enrichment
process included matches to three previously identified
HIV-1 miRNAs including hiv1-miR-N367, hiv1-miR-TAR-
3p, and hiv1-miR-H1. Furthermore, Wagschal et al. elu-
cidated the novel molecular mechanism by which the
abortive TAR transcripts are released and processed into
functional sncRNAs from promoter-proximal paused
RNA Polymerase II (Pol II) [10]. The findings from these
aforementioned studies supplants earlier work that failed
to identify miRNAs from retroviruses [11]. The primary
improvement with these more recent sequencing studies
that positively identified HIV-1 derived sncRNAs is the
depth of clones sequenced or enrichment of target clones,
which leads to a greater statistical power to detect low
abundance sncRNAs.
Using a similar methodology, the miRNA derived from
the 3′ stem-loop structure of the WNV genomic RNA
was first identified using bioinformatic techniques fol-
lowed by Northern blot detection and small RNA sequen-
cing from infected Aag2 mosquito cells [12]. Furthermore,
it was found that the processing of the WNV pre-miRNAs
into the mature 21nt miRNAs was Dicer1 dependent. As
this WNV miRNA has currently only been detected from
one strain of the virus and only from the vector Aag2
mosquito cell line, further validation of this viral miRNA
is required. However, the ability of WNV to encode a
miRNA increases the likelihood that other related cyto-
plasmically replicating RNA viruses encode their own
miRNAs.
As to point 2, the common functions of viral miRNAs
are to control viral life cycle, cell survival and immune
evasion, of which the BLV, WNV, and HIV-1 miRNAsree RNA viruses. Two retroviruses and one flavivirus, HIV, BLV, and
heir genomes. The identified viral miRNAs have been shown to elicit
ell as inhibiting viral transcriptional, thereby inducing latency.
wn to occur through diverse mechanisms of action, each of which
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NAs studied in more detail was found to be a mimic of
the oncogenic host miR-29 [2]. In regards to the WNV
miRNA, it was shown to up-regulate the host GATA4
expression, which increased viral genomic RNA replica-
tion [12]. Lastly, for the HIV-1 viral miRNAs, the TAR-
derived miRNA has the ability to induce latency, which
will be discussed in detail below.
Furthermore, in examining point 3, the HIV-1 TAR
sequence is highly conserved at the seed sequences with
95% identity across nearly all HIV-1 isolates. Likewise with
the miRNAs identified from BLV, four of the five predicted
seed sequences were identical across the seven isolates
examined [2]. As previously mentioned, the WNV encoded
miRNA will need to be validated by checking seed se-
quence homology across other related clades.
In further exploring point 2, we offer an explanation
of one specific viral miRNA being effective in the nu-
cleus which may directly contribute to viral latency. Spe-
cifically, high abundance unprocessed miRNAs, such as
TAR, and increased expression of the processed 50 or 30
terminus of the stem- and loop structure [10,13], results
in transcriptional gene silencing (TGS) of the HIV-1
promoter. TGS events can be easily scored in vivo by
using ChIP assays, as cells which have increased levels of
TAR miRNA show recruitment of enzymes (i.e., HDACs
and methyltransferases) involved in local epigenetic
modifications and transcriptional memory on the HIV-1
and specific cellular promoters [10,13]. This mode of
100% small RNA-DNA promoter complimentarity com-
plex or small RNA-mRNA hybridized complex may not
only explain the TGS seen on the HIV-1 promoter, but
also thousands of cellular promoters that have short
RNAs resulting from an stalled, unprocessive Pol II
bound to their promoters. The recent work by Wagschal
et al. specifically addressed this possibility and found that
TAR derived sncRNAs indeed inhibited HIV-1 LTR acti-
vity and induced chromatin remodeling. Moreover, they
found comparable Microprocessor recruitment and chro-
matin remodeling at human endogenous retroviral sites
within the genome indicating a more ancient conserved
mechanism by which retroviruses can be silenced [10].
Furthermore, the assumption that RNA viruses that
encode a miRNA may have their genome degraded by
Drosha, rendering them effete, may not be correct.
Along these lines, Berkhout’s lab has published studies
demonstrating that viral genomic RNA is shielded from
RNase activity [14]. Additionally, a recent paper exam-
ined the expression of cellular miRNAs inserted into the
Nef locus of an infectious HIV-1 genome [15]. In this
work it was shown that while insertion of miRNAs that
are efficiently processed did decrease viral replication,
insertion of less efficiently matured miRNAs did not
alter replication. Moreover, the non-canonical miRNAbiosynthesis pathways that have been recently identified
for the generation of the BLV miRNAs and TAR derived
miRNAs effectively evade potential full-length viral tran-
script cleavage and degradation [2,10].
Conclusion
Taken together the work by Kincaid et al. describes a fas-
cinating new finding on yet another retrovirus that not
only contains a viral miRNA made through a robust Pol
III promoter but also the possibility of control of viral and
cellular genes that could potentially make the host more
susceptible to viral regulation. Perhaps this line of research
is exactly what is needed to truly uncover the mysteries of
retroviral regulation of multiple genes through an RNA
element in higher eukaryotic cells.
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